Anti-cytokine treatments in Covid-19 disease: IL-6 receptor inhibitor (Tocilizumab) and IL-1 receptor antagonist (Anakinra) | Zendy

AI Assistant Blog Pricing

Open Access

Anti-cytokine treatments in Covid-19 disease: IL-6 receptor inhibitor (Tocilizumab) and IL-1 receptor antagonist (Anakinra)

Author(s) -

Atalay Doğru

Publication year - 2021

Publication title -

sdü tıp fakültesi dergisi

Language(s) - English

Resource type - Journals

eISSN - 2602-2109

pISSN - 1300-7416

DOI - 10.17343/sdutfd.897658

Subject(s) - anakinra , medicine , covid-19 , gynecology , gastroenterology , disease , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.